KALOSAR
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Jul 2022)
What this means for you
This application is over — abandoned 18 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88224364
- Mark type
- Stylized text
- Filed
- 11 Dec 2018
- Published for opposition
- 16 Apr 2019
- Abandoned
- 18 Jul 2022
- Attorney of record
- Maxim Voltchenko
Goods and services
- Class 005 — Pharmaceuticals: Dermatological preparations for the treatment of hyperproliferative diseases
Owner
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, US
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, US
Prosecution history
- 18 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2021 — SOU EXTENSION 5 GRANTED
- 19 Nov 2021 — SOU EXTENSION 5 FILED
- 29 Nov 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 01 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2021 — SOU EXTENSION 4 GRANTED
- 28 May 2021 — SOU EXTENSION 4 FILED
- 28 May 2021 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2020 — SOU EXTENSION 3 GRANTED
- 01 Dec 2020 — SOU EXTENSION 3 FILED
- 01 Dec 2020 — SOU TEAS EXTENSION RECEIVED